Prenatal Effects of Congenital Heart Disease (CHD) on Neurodevelopmental Outcome

Completed

Conditions studied: Congenital Heart Disease

In brief

The purpose of this study is to investigate the prenatal impact of abnormal cardiac structure on neurodevelopmental outcomes in children with congenital heart disease.

Key facts

Study ID

NCT00713635

Run by

Columbia University

People needed

51

Starts

2010-12-01

Expected to finish

2016-01-01

Last updated by the study team

2017-07-18

Who can join

Age: any, up to 50. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• All women who present to Columbia University Medical Center between 18-24 wks gestational age with the following fetal diagnoses will be invited to participate:
• Hypoplastic Left Heart Syndrome (HLHS)
• Transposition of the Great Arteries (TGA)
• Tetralogy of Fallot (TOF)
• Lung anomalies consisting of either congenital cystic adenomatoid malformations or bronchogenic cysts

You may not qualify if…

• Documented fetal chromosomal anomaly
• Structural brain malformations
• Evidence of placental insufficiency or Intrauterine growth retardation
• Documented hydrops fetalis or sustained cardiac arrhythmias
• Anticipated delivery at an outside hospital

Where it is running

• Columbia University College of Physicians & Surgeons, Morgan Stanley Children's Hospital of New York — New York, New York, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.